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Abstract 
Review on CEBPE, with data on DNA, on the 
protein encoded, and where the gene is implicated. 
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Identity 
Other names: CRP1 
HGNC (Hugo): CEBPE 
Location: 14q11.2 
Location (base pair) 
Starts at 23117306 and ends at 23119611 bp from 
pter (according to GRCh38.p7 Annotation Release 
108, May 5 2016) 
DNA/RNA 
Description 
CEBPE is located on chromosome 14q11.2 in a 
telomer-centromer orientation. Conflicting data 
have been published on the gene structure of 
CEBPE. According to the GRCh38.p7 assembly 
annotation (2016/03/21) the gene consists of two 
exons (1030 bp and 517 bp), which are partially 
coding and separated by a 759 bp intron (Figure 
1a). 
This is in conflict with some previously published 
papers. Yamanaka et al. (1997) described an  
alternative 3-exon-organization of the human 
CEBPE gene (Figure 1b). However, exon 1, as 
described by Yamanaka et al. contains a frameshift 
according to the GRCh38.p7 NCBI assembly. 
Transcription 
Various transcripts have been reported, resulting in 
four protein isoforms (Lekstrom-Himes 2001, 
Yamanaka 1997; Figure 1c). All transcripts share a 
common 3' end. 
Protein 
Description 
CEBPE is a member of the CCAAT/enhancer-
binding protein (C/EBP) family, which also 
includes CEBPA, CEBPB, CEBPG, CEBPD and 
CEBPZ (Ramji & Foka; 2002). A common 
structural feature of the C/EBP proteins is the 
presence of a highly conserved 55-65 amino acid 
sequence at the C-terminus which encodes a basic 
leucine zipper motif (bZIP domain) that functions 
as a dimerization domain. In the aminoterminal part 
all C/EBP proteins possess a DNA-binding domain 
with relative specificity for the CCAAT DNA 
motif. C/EBP proteins exert their physiological 
functions as either homo- or heterodimers. They 
can also interact with other bZIP- and non-bZIP 
transcription factors. Different protein domains 
have been characterized. The full-length CEBPE 
protein basically consists of an activation domain at 
the aminoterminal end, a repression domain in the 
center and the leucine zipper at the carboxyterminus 
(Williamson et al. 1998).  
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Figure 1: Human CEBPE gene and mRNA transcript:  a. according to the GRCh38.p7 assembly annotation (2016/03/21); b. 
according to Yamanaka et al. (1997); c. transcripts based on the Yamanaka exon organization 
 
At least four different CEBPE protein isoforms of 
32, 30, 27, and 14 kDa have been described, but 
their functional significance is unclear (Lekstrom-
Hines et al. 2001, Figure 1c).  
The CEBPE translation product can undergo a 
number of post-translational modifications. 
Phosphorylation of CEBPE on threonine 75, 
located in the transactivation domain, is associated 
with increased DNA binding capacity and 
transcriptional activation (Williamson et al., 2005). 
Sumoylation of lysine residues within the 
repression domain has been found to modulate 
CEBPE function (Kim et al., 2005). Acetylation of 
lysine-121 and lysine-198 was found to be critical 
for terminal neutrophil differentiation (Bartels et. 
al., 2015). 
Expression 
CEBPE is predominantly expressed in cells of the 
hematopoietic system and to a much lesser extent in 
ovarian tissue (Yamanaka, et al., 1997). In normal 
hematopoietic cells CEBPE is preferentially 
expressed in myeloid-committed cells and the 
protein is virtually only detectable in 
metamyelocytes and myelocytes. The gene is also 
expressed in more immature myeloid cells but 
protein translation is repressed by miRNA-130a 
(Larsen et al., 2014).  
 
The expression of CEBPE protein induces growth 
arrest, morphological differentiation, secondary 
granule proteins and has proapoptotic effects 
(Nakajima et al. 2006). 
Localisation 
Nuclear. 
Function 
CEBPE is a transcription factor, important for 
monocyte and granulocyte development. The 
transcription factor binds as a homodimer or 
heterodimer (with CEBPD) to specific DNA 
regulatory regions. Shorter CEBPE protein 
isoforms are hypothetical attenuators of the 
transcriptional activity of the long isoform.  
Homozygous CEBPE knock-out (-/-) mice appear 
healthy at birth but survive only 2-5 months after 
birth, while heterozygous CEBPE knock-out mice 
appear normal. CEBPE (-/-) mice showed a marked 
increase in immature myeloid progenitors, 
increased numbers of morphologically abnormal 
neutrophils, that were functionally defect and 
lacked an oxidative burst, and decreased numbers 
of eosinophils. Thus it was concluded that CEBPE 
is essential for a normal terminal differentiation of 
committed granulocyte progenitor cells (Yamanaka, 
et al., 1997). 
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Implicated in 
Neutrophil specific granule 
deficiency (SGD) 
Some, but not all of the very few known patients 
with SGD harboured CEBPE mutations which led 
to loss of the dimerization domain; phenotypically, 
SGD patients show bilobed nuclei, impaired 
chemotaxis and bactericidal activity with 
susceptibility to severe bacterial infections 
(Gombart & Koeffler 2002). 
Acute lymphoblastic leukemia (ALL) 
The CEBPE single nucleotide polymorphism 
rs2239633 has been implicated as a susceptibility 
factor for the development of B lineage ALL in 
children and adults. The relative risk (odds ratio) 
conferred is 1.1-1.6 (Papaemmanuil et al., 2009; 
Burmeister et al. 2014). 
t(14;14)(q11;q32) CEBPE/IGH and 
inv(14)(q11q32) CEBPE/IGH 
CEBPE is found recurrently translocated to the 
immunoglobulin heavy chain locus ( IGH) on 
14q32 in acute lymphoblastic leukemia patients 
with inv(14)(q11q32)/t(14;14)(q11;q32). The 
translocation leads to an overexpression of CEBPE 
under the control of the immunoglobulin heavy 
chain gene promoters. At least five cases have been 
described (Akasaka et al. 2007). 
References 
Akasaka T, Balasas T, Russell LJ, Sugimoto KJ, Majid A, 
Walewska R, Karran EL, Brown DG, Cain K, Harder L, 
Gesk S, Martin-Subero JI, Atherton MG, Brüggemann M, 
Calasanz MJ, Davies T, Haas OA, Hagemeijer A, Kempski 
H, Lessard M, Lillington DM, Moore S, Nguyen-Khac F, 
Radford-Weiss I, Schoch C, Struski S, Talley P, Welham 
MJ, Worley H, Strefford JC, Harrison CJ, Siebert R, Dyer 
MJ. Five members of the CEBP transcription factor family 
are targeted by recurrent IGH translocations in B-cell 
precursor acute lymphoblastic leukemia (BCP-ALL). Blood. 
2007 Apr 15;109(8):3451-61 
Bartels M, Govers AM, Fleskens V, Lourenço AR, Pals CE, 
Vervoort SJ, van Gent R, Brenkman AB, Bierings MB, 
Ackerman SJ, van Loosdregt J, Coffer PJ. Acetylation of 
C/EBPε is a prerequisite for terminal neutrophil 
differentiation. Blood. 2015 Mar 12;125(11):1782-92 
Burmeister T, Bartels G, Gröger D, Trautmann H, 
Schwartz S, Lenz K, Tietze-Bürger C, Viardot A, Wäsch R, 
Horst HA, Reinhardt R, Gökbuget N, Hoelzer D, Kneba M, 
Brüggemann M. Germline variants in IKZF1, ARID5B, and 
CEBPE as risk factors for adult-onset acute lymphoblastic 
leukemia: an analysis from the GMALL study group.  
Haematologica. 2014 Feb;99(2):e23-5 
Gombart AF, Koeffler HP. Neutrophil specific granule 
deficiency and mutations in the gene encoding 
transcription factor C/EBP(epsilon). Curr Opin Hematol. 
2002 Jan;9(1):36-42 
Han Y, Xue Y, Zhang J, Wu Y, Pan J, Wang Y, Shen J, 
Dai H, Bai S. Translocation (14;14)(q11;q32) with 
simultaneous involvement of the IGH and CEBPE genes in 
B-lineage acute lymphoblastic leukemia. Cancer Genet 
Cytogenet. 2008 Dec;187(2):125-9 
Kim J, Sharma S, Li Y, Cobos E, Palvimo JJ, Williams SC. 
Repression and coactivation of CCAAT/enhancer-binding 
protein epsilon by sumoylation and protein inhibitor of 
activated STATx proteins. J Biol Chem. 2005 Apr 
1;280(13):12246-54 
Larsen MT, Häger M, Glenthøj A, Asmar F, Clemmensen 
SN, Mora-Jensen H, Borregaard N, Cowland JB. miRNA-
130a regulates C/EBP-ε expression during granulopoiesis. 
Blood. 2014 Feb 13;123(7):1079-89 
Lekstrom-Himes JA. The role of C/EBP(epsilon) in the 
terminal stages of granulocyte differentiation Stem Cells  
2001;19(2):125-33 
Nakajima H, Watanabe N, Shibata F, Kitamura T, Ikeda Y, 
Handa M. N-terminal region of CCAAT/enhancer-binding 
protein epsilon is critical for cell cycle arrest, apoptosis, 
and functional maturation during myeloid differentiation J 
Biol Chem  2006 May 19;281(20):14494-502 
Papaemmanuil E, Hosking FJ, Vijayakrishnan J, Price A, 
Olver B, Sheridan E, Kinsey SE, Lightfoot T, Roman E, 
Irving JA, Allan JM, Tomlinson IP, Taylor M, Greaves M, 
Houlston RS. Loci on 7p12 2, 10q21 2 and 14q11 
Prasad RB, Hosking FJ, Vijayakrishnan J, Papaemmanuil 
E, Koehler R, Greaves M, Sheridan E, Gast A, Kinsey SE, 
Lightfoot T, Roman E, Taylor M, Pritchard-Jones K, 
Stanulla M, Schrappe M, Bartram CR, Houlston RS, 
Kumar R, Hemminki K. Verification of the susceptibility loci 
on 7p12 2, 10q21 2, and 14q11 
Ramji DP, Foka P. CCAAT/enhancer-binding proteins: 
structure, function and regulation Biochem J  2002 Aug 
1;365(Pt 3):561-75 
Williamson EA, Williamson IK, Chumakov AM, Friedman 
AD, Koeffler HP. CCAAT/enhancer binding protein epsilon: 
changes in function upon phosphorylation  by p38 MAP 
kinase Blood  2005 May 15;105(10):3841-7 
Yamanaka R, Kim GD, Radomska HS, Lekstrom-Himes J, 
Smith LT, Antonson P, Tenen DG, Xanthopoulos KG. 
CCAAT/enhancer binding protein epsilon is preferentially 
up-regulated during granulocytic differentiation and its 
functional versatility is determined by alternative use of 
promoters and differential splicing Proc Natl Acad Sci U S 
A  1997 Jun 10;94(12):6462-7 
This article should be referenced as such: 
Burmeister T. CEBPE (CCAAT/enhancer binding protein 
epsilon). Atlas Genet Cytogenet Oncol Haematol. 2017; 
21(12):438-440. 
